Jinjin Jia

No ORCID on file · 16 papers in corpus · active 2024-2026

Study types

  • article 10
  • other 5

Condition tags

  • endometriosis 14
  • adenomyosis 1
article 2026
Additional file 1 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330008.v1

Supplementary Material 1: 14 herbs of LSNYP.

article 2026
Additional file 1 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330008

Supplementary Material 1: 14 herbs of LSNYP.

article 2026
Additional file 2 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330011.v1

Supplementary Material 2: 114 Potential active components.

article 2026
Additional file 2 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330011

Supplementary Material 2: 114 Potential active components.

article 2026
Additional file 3 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330014

Supplementary Material 3: 217 potential therapeutic targets.

article 2026
Additional file 3 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330014.v1

Supplementary Material 3: 217 potential therapeutic targets.

article 2026
Additional file 4 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330017.v1

Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.

article 2026
Additional file 4 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330017

Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.

2026
Luoshi Neiyi prescription mitigates endometriosis by modulating nuclear receptor subfamily 5 group A member 1 methylation
International journal of biological macromolecules ·doi:10.1016/j.ijbiomac.2026.153016

OBJECTIVE: This study aimed to investigate the mechanisms underlying Nuclear Receptor Subfamily 5 Group A Member 1 (NR5A1, encoding SF-1) hypomethylation in endometriosis (EMs) and to evaluate the effects of Luoshi Neiyi Prescription (LSNYP…

other 2026
Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.c.8307684

Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…

other 2026
Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.c.8307684.v1

Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…

other 2026
Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
Hereditas ·doi:10.1186/s41065-026-00637-2

BACKGROUND: Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecular mech…

other 2025
Shaoyao gancao decoction induces autophagy by modulating miR-21 and inhibiting the AKT/mTOR signaling pathway in adenomyosis-derived ectopic endometrial stromal cells
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1665911

ETHNOPHARMACOLOGICAL RELEVANCE: Shaoyao Gancao Decoction (SGD) is a renowned traditional Chinese medicinal formulation widely utilized in Asia. It is particularly effective in treating spastic, painful, and inflammatory conditions, especial…

article 2024
Construction and evaluation of endometriosis diagnostic prediction model and immune infiltration based on efferocytosis-related genes
Frontiers in molecular biosciences ·doi:10.3389/fmolb.2023.1298457

Background: Endometriosis (EM) is a long-lasting inflammatory disease that is difficult to treat and prevent. Existing research indicates the significance of immune infiltration in the progression of EM. Efferocytosis has an important immun…

article 2024
Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway
Journal of ethnopharmacology ·doi:10.1016/j.jep.2024.118659

ETHNOPHARMACOLOGICAL RELEVANCE: Endometriosis (EMS) is a common gynecological disease that causes dysmenorrhea, chronic pelvic pain and infertility. Luoshi Neiyi Prescription (LSNYP), a traditional Chinese medicine (TCM) formula, is used to…

other 2024
Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1395160

INTRODUCTION: Endometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active che…